Challenges with gene expression profiling in a biotech setting and recent technical advances with NanoString PlexSet™
|SPEAKER:||Matt Goddeeris, Principal Scientist, Mitobridge|
Jan 24, 2018
Mitobridge, a clinical-stage biopharmaceutical company developing small molecule therapeutics that improve mitochondrial function, has used the NanoString PlexSet format for gene expression since its launch in Spring 2017. This webinar discusses systematically interrogating disease-related changes in mitochondrial activity and translating unique insights into potential new treatments with technical reproducibility using PlexSet Reagents.
FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.